Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells
Science Advances · 2025
DOI: 10.1126/sciadv.ads5434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Zi-Jian Cao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metaboli…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Unfolded Protein Response, Hedgehog Proteins, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The unfolded protein response (UPR) pathway is crucial for tumorigenesis, mainly by regulating cancer cell stress responses and survival. However, whether UPR factors facilitate cell-cell communication between cancer cells and immune cells to drive cancer progression remains unclear. We found that adenosine 3′,5′-monophosphate response element–binding protein 3–like protein 2 (CREB3L2), a noncanonical UPR factor, is overexpressed and activated in triple-negative breast cancer, where its cleavage releases a C-terminal fragment that activates the Hedgehog pathway in neighboring CD8+ T cells. The enhanced Hedgehog pathway represses CD8+ T cell activation and inhibits its cytotoxic effects. Consequently, overexpression of CREB3L2 not only promotes tumor growth but also causes resistance to immune checkpoint blockade (ICB). Inhibition of the Hedgehog pathway impedes the growth of CREB3L2-overexpressed tumors and sensitizes them to ICB therapy. In summary, we identified a previously unidentified mechanism by which the UPR pathway dictates cross-talk between cancer cells and immune cells, providing important anticancer therapeutic opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang University School of…
- Institute of Fundamental and Transdisciplinary Research, Cancer Center, Zhejiang University, Hangzhou, China.
- School of Life Sciences, Westlake University, Hangzhou, China.
- K2 Oncology Co., Ltd., Beijing, China.
- Department of Pathology, First Central Hospital of Baoding, Baoding, China.
- Hebei Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor, Baoding, China.
ORCID-Profile: Zi-Jian Cao, Jia You, Zhongwu Li, Yu-Xiong Feng
Zitieren
APA
Cao, Z. J., You, J., Fan, Y. M., Yang, J. Y., Sun, J., Ma, X., Zhang, J., Li, Z., Wang, X., & Feng, Y. X. (2025). Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells. Science Advances. https://doi.org/10.1126/sciadv.ads5434
Vancouver
Cao ZJ, You J, Fan YM, Yang JY, Sun J, Ma X, et al. Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells. Science Advances. 2025. doi:10.1126/sciadv.ads5434
BibTeX
@article{Cao2025,
author = {Cao, Zi-Jian and You, Jia and Fan, Yu-Meng and Yang, Jia-Ying and Sun, Jirui and Ma, Xiuli and Zhang, Jinku and Li, Zhongwu and Wang, Xiang and Feng, Yu-Xiong},
title = {Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ads5434}
}
EUVIMED